Maraviroc treatment for hospitalized participants with non-severe COVID-19 at risk of progression: a randomized, proof-of-concept clinical trial
Carmen Gasca‐Capote, José Manuel Lomas-Cabezas, Abraham Saborido-Alconchel, Cristina Moral-Turón et autres